Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease in Adults
Phase of Trial: Phase II
Latest Information Update: 30 May 2012
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 30 May 2012 Actual end date changed from Aug 2008 to Jul 2008 as reported by ClinicalTrials.gov.
- 30 May 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.